Federal contractor · SUGAR LAND, TX

QUVA PHARMA, INC.

QUVA PHARMA, INC. received $55.7K in federal contract obligations in FY2026, on 2 awards. Since FY2017: $1.7M. Its largest customer was National Institutes of Health ($55.7K).

Obligations · FY2026
$55.7K
New awards
2
Sole-source
0.0%
Single offer
100%
UEI
MUABDCZXMLG4
Parent company
QUVA PHARMA INC.
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 54.4KFY2017
  2. 203.7KFY2018
  3. 112.1KFY2019
  4. 295.8KFY2020
  5. 177.3KFY2021
  6. 293.3KFY2022
  7. 211.1KFY2023
  8. 405.4KFY2024
  9. -84.8KFY2025
  10. 55.7KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$55.7K100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$55.7K100%

Where the work was performed

  1. Fort Bend County, TX$55.7K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $110K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.8% · $110K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC.$110K
    National Institutes of Health· Montgomery County, MD· Health & medical· May 26, 2026 – May 29, 2026· 75N98026P00592
  2. QUVA PHARMA, INC.:1327585 [POTS: 20-001401]$45.7K
    National Institutes of Health· Fort Bend County, TX· Health & medical· Mar 6, 2020 – Apr 30, 2026· 75N90020F00001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. VITAE ENIM VITAE SCIENTIFIC, INC.$382K
    SAN DIEGO, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. UNITED BIOPHARMA, INC.$400K
    HSINCHU COUNTY, TWN · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. BIOLEGEND, INC.$373.6K−82% in FY2026
    SAN DIEGO, CA · 95% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

  • Quva Pharma, Inc.AI match · 100%
  • Quva Pharma, Inc. (fka QuVa Pharma, Inc.)AI match · 99%
Lobbying · 2025
$190K
4 reports
Lobbying · 2023–2026
$560K

Lobbying by year

  1. 2023$100K
    2 reports
  2. 2024$170K
    4 reports
  3. 2025$190K
    4 reports
  4. 2026$100K
    2 reports

Top issues

  1. Pharmacy9 reports

Who was contacted

  1. U.S. SENATE8 reports
  2. U.S. HOUSE OF REPRESENTATIVES7 reports
  3. Centers For Medicare and Medicaid Services (CMS)2 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. Van Scoyoc Associates$310K
    7 reports
  2. PRIME POLICY GROUP$250K
    5 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 3, 2026, loaded Oct 3, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 3, 2026, loaded Oct 3, 2026 · 2026, 2024, 2022.

Matches: AI name judgments (entity-match@1, jev-1.13.0), updated Sep 30, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.